logo-loader

RegMed Daily, Mid-Day, 12/8/11, buy the euro rumor, sell any euro news

Last updated: 15:19 08 Dec 2011 GMT, First published: 20:19 08 Dec 2011 GMT

no_picture_pai

  The 6 W’s: Who, what, where, when, why and what of it …

 

Macro EU issues continue to … overwhelm the markets

 

 

Mid-Day: The NASDAQ is DOWN -36.05 (-1.36%) to 2,613.16. The Dow is DOWN -161.70 (-1.33%) to 12,034.67.

 

 

Mid-Day Movers:  ImmunoCellular (OTC BB: IMUC), Pluristem (PSTI) and ReNeuron (RENE.LON)

 

 

What’s new in the regenerative medicine/stem cell market … not much

 

NeoStem (AMEX: NBS) 2 New Board of Directors: 2 appointments to its Board of Directors: Martyn D.Greenacre, who formerly served on the board of Cephalon and Dr. Andrew L. Pecora currently Chief Medical Officer of NBS. https://www.scimitarequity.com/blog/2011/12/08/neostem-amex-nbs-2-new-board-of-directors

Chesnara reports strong 2023 results with improved cash generation and...

Chesnara PLC (LSE:CSN) chief executive Steve Murray discusses the company's full-year results for 2023 with Proactive's Stephen Gunnion, describing them as strong and particularly highlighting £53 million in commercial cash generation and a dividend coverage of around 150%. The company has...

33 minutes ago